Every minute, a person dies in Europe due to thrombosis. This October 13 is World Thrombosis Day, and for that reason, we want to give a voice to this disease, which is often invisible but has serious consequences. Thrombosis occurs when blood clots form in veins or arteries, partially or completely blocking blood circulation. This condition can trigger complications such as heart attacks, strokes, or pulmonary embolisms, and it is the leading global cause of mortality related to cardiovascular diseases.
Dr. José Manuel Soria, head of the Genomics of Complex Diseases group at the Sant Pau Research Institute, highlights the importance of understanding the risk factors of this disease, which range from genetics to environmental causes. “It is a complex combination of genetic and environmental factors,” explains Dr. Soria. These factors can include prolonged immobilization, major surgeries, pregnancy, use of contraceptives, or other illnesses such as cancer or severe infections like COVID-19. It is essential to understand these risk factors to prevent this disease.
At Sant Pau, thrombosis research is a priority. Our researchers are working to develop new biomarkers that can help predict which patients are at higher risk of thrombosis, enabling the application of personalized treatments that reduce mortality.
To mark World Thrombosis Day, the Activa’TT Association and the Sant Pau Research Institute are organizing an event to launch one of their fundraising projects: the presentation of the book La vida corre per les teves venes, a work that shares the experiences of renowned mountaineers and their connection to thrombosis. Some of them have experienced this disease, showing how it can affect anyone.
The book will be available in the coming weeks and can be purchased through this link. The proceeds will be directed to thrombosis research, particularly in cancer patients, one of the most vulnerable groups.
You can support this cause by purchasing the book or making a direct donation through this link. We encourage you to become aware of this disease and collaborate in the research that will allow us to advance its prevention and treatment.
